<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-ZTU6GFTC</identifier><date>2025</date><creator>Andlovic, Aljoša</creator><creator>Novak, Nadja</creator><relation>documents/doc/Z/URN_NBN_SI_doc-ZTU6GFTC_001.pdf</relation><relation>documents/doc/Z/URN_NBN_SI_doc-ZTU6GFTC_001.txt</relation><format format_type="issue">1</format><format format_type="volume">29</format><format format_type="type">article</format><format format_type="extent">str. 42-44</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">239053571</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-ZTU6GFTC</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">imunske bolezni živčnega sistema</subject><subject language_type_id="slv">toksičnost zdravil</subject><subject language_type_id="slv">zaviralci imunskih nadzornih točk</subject><title>Nevrološki zapleti zdravljenja z zaviralci imunskih nadzornih točk</title><title>prikaz primera</title><title>Neurological adverse events of immune checkpoint inhibitors</title><title>case report</title></Record>